3458 results for «30MDL多少人民币»

Filter By

3458 results

Bubble trouble: aortic air embolization and de-embolization during coronary angiography

09 Aug 2021

Air embolism (AE) is a rare complication during interventional procedures and one of the most scaring for interventional cardiologists. Air bubbles in the coronary circulation often result in ischemic symptoms, vasospasm, and even cardiac arrest. In addition, arrhythmias are common and closely related to the coronary ...

Bubbles trouble: Aortic Air embolization and de embolization during coronary angiography

TRISCEND: six-month outcomes of transfemoral tricuspid valve replacement in patients with TR - a written review

09 Nov 2021

 

The 6-month follow-up of the TRISCEND study was presented during the TCT Congress 2021 by principal investigator Susheel Kodali. Alessandro Sticchi & Jonathan Curio offer a review of this trial.

Alessandro Sticchi

Author

Alessandro Sticchi
Jonathan Curio

Author

Jonathan Curio
TRISCEND Study: six-month outcomes of transfemoral tricuspid valve replacement in patients with tricuspid regurgitation

The PASCAL IID Registry: A prospective registry for transcatheter edge-to-edge repair in prohibitive risk patients with degenerative mitral regurgitation and complex mitral valve anatomy

17 Sep 2022

Alex Sticchi provides his take on the PASCAL IID Registry and an initial comparison with the CLASP IID. The trial was presented by Jörg Hausleiter during TCT Congress 2022.

Alessandro Sticchi

Author

Alessandro Sticchi
The PASCAL IID Registry: A Prospective Registry for Transcatheter Edge-to-Edge Repair in Prohibitive Risk Patients With Degenerative MR and Complex Mitral Valve Anatomy

EXpansion of stents after Intravascular lithoTripsy versus conventional predilatation in CALCified coronary arteries: the EXIT-CALC – a prospective, randomized study

20 Sep 2022

Pierre Deharo and Michele Pighi share with us their views on the EXIT-CALC study presented by Thomas Oomens at TCT 2022.

Pierre Deharo

Author

Pierre Deharo
M. Pighi

Author

Michele Pighi
EXpansion of stents after Intravascular lithoTripsy versus conventional predilatation in CALCified coronary arteries: the EXIT-CALC – a prospective, randomized study

The PRE18FFIR trial: Coronary Plaque Activity to Predict Recurrent Events

01 Sep 2022

Alex Sticchi provides his take on the PRE18FFIR trial: Prediction of recurrent events with 18F-Sodium Fluoride to identify ruptured and high-risk coronary artery plaques in patients with myocardial infarction.

Alessandro Sticchi

Author

Alessandro Sticchi
The PRE18FFIR trial: Coronary Plaque Activity to Predict Recurrent Events

Meril presents successful LANDMARK RCT one-year results at prestigious EuroPCR 2025

21 May 2025

Primary and secondary outcomes of the Women's Ischemia Trial to reduce events in non-obstructive coronary artery disease (WARRIOR)

31 Mar 2025

Nicola Ryan provides her take on the WARRIOR trial which was presented by Eileen Handberg at ACC.25 in Chicago.

The manuscript for this trial has not been published and all assumptions are based upon the presentation.

Nicola Ryan

Author

Nicola Ryan
Primary and secondary outcomes of the Women's Ischemia Trial to reduce events in non-obstructive coronary artery disease

Pi-Cardia reports first commercial cases with ShortCut™

03 Mar 2025

Pi-Cardia’s ShortCut™ Becomes First Leaflet Modification Technology to Receive CMS NTAP for Valve-in-Valve TAVR

06 Aug 2025

TARGET-FIRST: Early aspirin discontinuation after PCI in low-risk acute MI patients

01 Sep 2025

Elad Asher provides his take on the results of TARGET-FIRST presented by Giuseppe Tarantini at the ESC Congress 2025 in Madrid.

Elad Asher

Author

Elad Asher
TARGET-FIRST

Complex PCI supported by a guide catheter extension system through the frames of a self-expandable trans-catheter heart valve

05 Jun 2020

An 84-year-old man with arterial hypertension and previous hepatocellular carcinoma was admitted to our Emergency Department for new onset of exertional angina (CCS 3). The patient had a history of three-vessel coronary artery disease treated by complete surgical revascularization in 2007...

Image in cardiology: Catheter extension-assisted post-TAVR PCI

Robocath performs world’s First-In-Human remote robotic coronary angioplasty between two Chinese cities 1,700 miles apart

14 Dec 2023

Jupiter Endovascular closes oversubscribed Series B Financing, surpassing $40 million target

07 Oct 2025

Jupiter endovascular announces completion of enrollment in SPIRARE II pivotal trial

04 Feb 2026

FFR or 3d-quantitative coronary angiography-based vessel-FFR guided revascularisation – The FAST III trial

28 Mar 2026

Chiara De Biase provides her take on the FAST III Trial presented by Joost Daemen at ACC.26 in New Orleans. She reviews the comparison between vFFR and FFR, highlighting key findings and their impact on revascularisation strategies.

Author

Chiara De Biase
FAST III: FFR vs 3D-QCA vessel-guided revascularisation

Simultaneous publications EuroPCR 2025

View the list of EuroPCR 2025 simultaneous publications in different cardiology and interventional cardiology journals
Simultaneous publications EuroPCR 2025

DAPT-SHOCK-AMI trial: Cangrelor in cardiogenic shock

03 Sep 2025

Kalaivani Mahadevan and Fizzah Choudry provide their take on DAPT-SHOCK-MI presented by Zuzana Motovska at ESC Congress 2025 in Madrid.

Fizzah Choudry

Author

Fizzah Choudry
Kalaivani Mahadevan

Author

Kalaivani Mahadevan
DAPT-SHOCK-AMI trial: Cangrelor in cardiogenic shock

Implantation of the Portico With FlexNav TAVI System in a patient with aortic stenosis, severe renal impairment, and diffuse iliac atherosclerosis

12 May 2020

Real-world case report illustrating the benefits of the Portico with FlexNav TAVI system.

Implantation of the Portico With FlexNav TAVI System in a patient with aortic stenosis, severe renal impairment, and diffuse iliac atherosclerosis

RIVER: Rivaroxaban for valvular heart disease and atrial fibrillation

05 Sep 2023

Alex Sticchi provides his take on the results of the RIVER trial, which were presented by Pedro Gabriel Barros E Silva during the ESC 2023 congress in Amsterdam.

Rivaroxaban versus Warfarin in Patients with Bioprosthetic Valves According to Valvular Heart Disease Etiology, and Thrombotic and Bleeding Risks: Insights from...

Alessandro Sticchi

Author

Alessandro Sticchi
RIVER: Rivaroxaban for valvular heart disease and atrial fibrillation

EuroPCR 2024 – Andreas Grüntzig Ethica Award winners of EuroPCR 2024: Ottavio Alfieri and Frederick St Goar

15 May 2024

Paris, France, 15 May 2024. During each edition of EuroPCR, the Andreas Grüntzig Ethica Award, which recognises outstanding achievements and contributions to the cardiovascular field, is presented. On 15th May, at the Palais des Congrès, Porte Maillot in Paris, a special ceremony was held to bestow...

Didn’t find what you were looking for?